S. Rea is the first author of a 2000 study identifying SUV39H1 and its mouse counterpart as histone methyltransferases with a specific target: lysine 9 near the beginning of histone H3. In experiments outside living biological cells, these enzymes transferred methyl groups to that position. Mapping the catalytic activity implicated the SET domain together with neighboring regions rich in cysteine.^[ref]

The specificity is the important idea: a histone modification has an address within a protein, rather than simply changing the bulk composition of chromatin. The study also found that modification of lysine 9 interfered with phosphorylation of neighboring serine 10, illustrating how nearby chemical changes can interact. Experiments that altered the enzymes' activity in biological cells also changed histone H3 phosphorylation and produced abnormal divisions. These observations helped connect a defined catalytic reaction with the regulation of chromatin; they did not imply that every modified histone has the same effect in every biological context.^[ref]

M. Schena is the first author of a 1995 demonstration of parallel gene expression measurement using a DNA microarray. The team robotically printed Complementary DNA on glass, turning the positions of small spots into addresses for different genes. Simultaneous measurements with two colors of fluorescence compared expression of 45 genes from Arabidopsis thaliana. The small array permitted a reaction volume of two microlitres and probes prepared from two micrograms of cellular messenger RNA.^[ref]

The useful change was from measuring one gene at a time to comparing many genes within the same experiment. As a simplified numerical illustration, comparable, corrected fluorescence signals of 400 and 100 units at one spot would give a ratio of four. That ratio concerns the assay's RNA-derived signal under its measurement assumptions; it is not automatically a fourfold change in the amount or activity of the corresponding protein. The original experiment was a 45-gene demonstration, so its scope should not be confused with a measurement of an entire human genome.

Michael J. Knight is the first author of a 2016 study that reconstructed biological silicon transport using purified proteins. The investigators placed diatom silicon transporters in artificial liposomes, then measured entry of silicic acid with an internal zinc-dependent fluorescence assay. Applying a sodium gradient let them investigate transport outside the many interacting processes of a living biological cell.^[ref]

The measured transport saturated as the silicic acid concentration increased, with apparent Michaelis constants near 20 micromolar for two of the tested proteins. For an illustrative saturation law $v/V_{\max }=C/(K_M+C)$ with $K_M=20$ micromolar, increasing $C$ from 20 to 80 micromolar increases the predicted rate from $0.5V_{\max }$ to $0.8V_{\max }$, rather than multiplying it by four. The experiment therefore connects a mineral nutrient with a quantifiable molecular transport process. Its fluorescence signal came from an indicator reaction, so calibration and background controls were essential.^[ref]

J. L. van Rijn is the first author of a 1984 study of how membrane composition and an accessory protein affect activation of prothrombin. The investigators varied phospholipid concentration and composition, with and without factor Va, and measured the action of factor Xa on bovine prothrombin. This tested an enzyme in a membrane-associated reaction system rather than assuming that its behavior in solution determines the whole process.^[ref]

For vesicles containing 20 mole percent phosphatidylglycerol and 80 mole percent phosphatidylcholine, the reported apparent Michaelis constant for prothrombin was 0.04 micromolar with factor Va, compared with 2.2 micromolar without it. The ratio is $2.2/0.04=55$. That comparison shows the scale of the change in an apparent kinetic parameter; it is not a claim that the reaction rate increases 55-fold at every substrate concentration. The experiment illustrates how a surface and an accessory protein can change the effective behavior of a biochemical reaction.^[ref]

Rustem I. Litvinov studies the molecular mechanics of fibrin, the protein network formed during coagulation. A 2005 study led by Litvinov used optical tweezers to measure forces between individual interacting molecules. It examined fibrin knob-hole interactions, in which an exposed part of one molecule fits into a complementary binding pocket on another.^[ref]

The apparatus repeatedly brought a protein-coated bead into contact with a coated surface, then pulled the partners apart. The force rose while they remained attached and dropped when attachment ruptured. Removing a complementary binding part or adding a competing peptide suppressed the strong interactions. These controls helped distinguish specific molecular recognition from nonspecific adhesion. Forces around 125–130 piconewtons characterized the strong interactions under the experiment's pulling conditions. Such rupture measurements connect molecular assembly to mechanics, but the numerical rupture force is not a universal constant independent of how a bond is loaded.^[ref]

Roberto Vanacore investigates the chemistry of the extracellular matrix, particularly the collagen networks supporting tissues. A 2009 study led by Vanacore identified an unusual sulfilimine bond joining neighboring Collagen IV units. The team combined mass spectrometry with nuclear magnetic resonance to establish a sulfur–nitrogen connection between methionine and hydroxylysine.^[ref]

The discovery makes a useful distinction between seeing that two proteins are joined and determining the chemical identity of the join. Precise mass constrains the atoms present, while spectroscopic measurements provide additional evidence about their arrangement. Together these methods resolved a link whose identification had been difficult from structural images alone. The crosslink reinforces the Collagen IV scaffold of basement membranes, connecting atomic bonding with tissue-scale mechanical organization.^[ref]

Florian Brueckner coauthored structural experiments on how RNA polymerase II moves along DNA during transcription. With Patrick Cramer, he prepared crystals containing an elongating enzyme complex in which states before and after movement could interconvert. Soaking the crystals with alpha-amanitin trapped a new arrangement interpreted as a possible intermediate. The resulting X-ray crystallography structure was refined at 3.4 angstrom resolution.^[ref]

The entering DNA base lay above a displaced RNA polymerase bridge helix, while the RNA polymerase trigger loop adopted a wedged arrangement. The authors proposed that the inhibitor restricts movement of these parts, interfering with both nucleotide incorporation and advancement. This illustrates a productive use of inhibition: slowing a molecular machine can make otherwise transient arrangements accessible to structural measurement. The data support a mechanistic model, rather than providing a direct movie of every motion in a living biological cell.^[ref]

Patrick Cramer studies the molecular machinery of transcription: how RNA polymerases copy information from DNA into RNA. His work connects the three-dimensional structures of these enzymes with the steps by which they add nucleotides and advance along a template. ^[ref]

With Florian Brueckner, Cramer used alpha-amanitin to trap a possible intermediate in the movement of RNA polymerase II. A structure at 3.4 angstrom resolution showed a shifted RNA polymerase bridge helix and a particular position of the RNA polymerase trigger loop.^[ref]

A useful way to understand this strategy is to distinguish an enzyme's chemical reaction from its mechanical reset: after extending an RNA chain, the machinery must position the next template base. Trapping different arrangements can reveal how those tasks are coordinated. A trapped structure is a snapshot under experimental conditions, however, so assigning it to the normal reaction cycle also requires biochemical evidence.

A. M. de Vos investigated how growth hormone binds its growth hormone receptor. With colleagues, de Vos determined the X-ray crystallography structure of a complex containing human growth hormone and the extracellular portion of its receptor. The 1992 structure, measured at $2.8\text{A˚}$, contained one hormone molecule and two receptor molecules.^[ref]

The growth hormone molecule contacted the two receptors through different binding surfaces, although the receptors used largely the same residues in each contact. Additional contact between the two receptors supported a model in which hormone binding brings a receptor pair together. This made the geometry of signal transduction concrete: a single bound hormone can organize more than one receptor molecule. The measured complex contained extracellular fragments, so the structure did not by itself record the complete activation process across a cell membrane.^[ref]

Nicola Pozzi investigates the molecular mechanisms of thrombosis, including how protein structure controls the conversion of prothrombin into thrombin. His work combines biochemical measurements with structural and single-molecule methods.^[ref]

In a 2013 study, Pozzi and colleagues combined X-ray crystallography with measurements of distances within prothrombin in solution. Their engineered protein lacked the Gla domain and replaced catalytic serine 525 with alanine. Measurements supported two major arrangements in solution rather than one rigid shape. The distinction matters because prothrombin is a zymogen: activation requires cutting particular peptide bonds, and folding can expose or conceal the relevant sites. The study connected structural flexibility with access to those sites; its engineered construct and experimental conditions limit how directly a single observed arrangement can describe native prothrombin in every setting.^[ref]

Averell L. Gnatt studied the protein structure of RNA polymerase II, the enzyme that carries out much of eukaryotic transcription. In 2001, he and colleagues determined an X-ray crystallography structure of an actively transcribing complex at a spatial detail of $3.3\text{A˚}$. The complex contained both the DNA template and the growing RNA, allowing their paths through the enzyme to be followed.^[ref]

Incoming paired DNA entered a cleft and separated before the active site. A nine-base-pair DNA-RNA hybrid held the newly copied region, while the growing RNA end lay at the site where the next nucleotide would be added. Thus only a short local stretch of the product remained paired to its template: the rest of the RNA could leave as copying continued. Comparison with the free enzyme also showed closure of a protein clamp over the bound DNA and RNA, connecting a change in protein structure with stable engagement during transcription.^[ref]

D. Heinegård investigated the molecular organization of cartilage proteoglycans. A 1974 study with colleagues dissected large proteoglycan assemblies using controlled proteolysis, gel filtration and gel electrophoresis.^[ref]

Digestion yielded a fraction derived from the proteoglycan core protein and a distinct linking protein fraction. Both retained binding to hyaluronic acid. Separating components while testing which interaction survives is a useful way to infer how a large molecular assembly is held together: the original aggregate's size alone does not identify its binding partners.^[ref]

I. G. Panyutin studied the physical chemistry of DNA strand exchange. In 1994, work with P. Hsieh measured spontaneous branch migration, the motion of an exchange junction along homologous double-stranded DNA.^[ref]

The experiments varied temperature and ions while using defined DNA substrates. Removing magnesium accelerated the reported process by roughly a thousandfold. The comparison illustrates why an observed reaction rate is not a property of the DNA sequence alone: solution conditions can alter junction geometry and therefore how readily exchange proceeds.^[ref]

P. Hsieh investigated DNA reactions involved in genetic recombination. A 1994 study with I. G. Panyutin isolated spontaneous branch migration of a Holliday junction for kinetic measurement.^[ref]

Complementary single-stranded ends joined two double-stranded DNA substrates into a four-stranded junction. Movement to the far end produced strand-exchanged products. Measuring that conversion under different solution conditions showed that the surrounding ions, especially magnesium, strongly changed the rate. This separated a physical DNA reaction from the additional regulation supplied by cellular proteins.^[ref]

M. W. Pantoliano investigated ways to use protein thermal stability in molecular screening. A 2001 study developed automated, miniaturized thermal shift assays exploiting the coupling between ligand binding and protein unfolding.^[ref]

The motivating problem was scale: a new protein target may lack a convenient functional assay. Measuring its thermal response can provide a common experimental readout across many targets. This does not remove the need to test what a candidate compound actually does to the target's biological activity.^[ref]

Mei-Chu Lo investigated experimental methods for detecting ligand binding to proteins. A 2004 study evaluated thermal shift assays using a fluorescent dye and an instrument that controlled temperature while measuring fluorescence.^[ref]

The study compared binding estimates with isothermal titration calorimetry and examined relationships with enzyme activity assays. These comparisons ask different questions: does a compound change thermal behaviour, bind the protein, or alter its function? Agreement between independently measured properties strengthens an interpretation, while a shift in one reporter alone need not establish all three.^[ref]

Lei Jin coauthored structural research on how heparin activates the inhibitory protein antithrombin. A 1997 paper compared crystallographic structures involving active and latent antithrombin and its high-affinity five-sugar binding sequence at 2.9-ångström resolution.^[ref]

The study linked binding to changes in the main beta sheet and exposure of the reactive-center loop, providing a structural account of how a carbohydrate ligand changes the behaviour of a serpin.^[ref] The point is more informative than simply observing that heparin and antithrombin bind: the locations of structural changes suggest how binding can alter access to the inhibitory machinery.

A structure is a constrained molecular snapshot. Establishing a complete time sequence or the rate of inhibition requires additional kinetic evidence; it cannot be read directly from a static arrangement of atoms.

George E. Fox is a researcher in ribosome function, ribosomal RNA structure and molecular evolution. The University of Houston identifies him as a co-discoverer of Archaea and describes his laboratory's use of comparative analysis to investigate ribosomal RNA organization and the evolution of the ribosome.^[ref]

In 1977 Fox was first author of a study characterizing 16S ribosomal RNA from ten methane-producing microbial species. Digestion with ribonuclease T1 generated short fragments for ribosomal RNA oligonucleotide cataloguing. Comparing the catalogs revealed a distinct evolutionary group, distant from typical bacteria.^[ref] Fox and Carl R. Woese then jointly published the broader proposal distinguishing three primary lines of descent.^[ref]

The catalog comparison used an association coefficientwhere $N_A$ and $N_B$ count nucleotide residues represented by catalogued fragments of at least six nucleotides, and $N_{AB}$ counts the residues in their shared sequences. The weighting is by represented residues, rather than merely by the number of different fragment strings.^[ref]

For a constructed pair with $N_A=100$, $N_B=140$ and $N_{AB}=60$, the coefficient is $120/240=0.5$. Identical catalogs would give one, and no overlap would give zero. This arithmetic explains the comparison's normalization; the value is not directly a fraction of whole-genome identity or a calibrated divergence time.

Fox's work helped make evolutionary relationships among superficially similar microorganisms experimentally accessible through a shared molecular system, the ribosome.

Thomas Wicker is a researcher in genomics whose work includes transposable elements and the evolution of plant genomes. In 2007 he and collaborators proposed a unified hierarchical classification to make element identification and genome annotation more consistent across organisms. The publisher lists Wicker among three equally contributing authors.^[ref]

Their framework distinguishes elements using an RNA intermediate from those without one, while incorporating additional mechanistic and structural criteria. It also offers practical sequence-based guidelines for grouping closely related elements, rather than equating every recognizable fragment with a new type.^[ref]

A constructed alignment example makes the denominators explicit. Suppose a relevant region is one thousand nucleotides long, eight hundred are aligned, and six hundred and forty of the aligned positions match. The aligned-region identity is $640/800=80\%$, while alignment coverage is $800/1000=80\%$. Dividing matches by the whole region instead gives $64\%$, a different quantity. The proposal uses identity, covered region and a minimum comparison length as separate considerations; the example illustrates those distinctions rather than defining a universal biological boundary.

The paper also separates the apparent presence of the necessary coding domains from proof of activity. An element can retain those domains yet contain disabling changes. Classification from a sequence therefore does not alone demonstrate that the element moves in a living cell.^[ref]

Koreaki Ito is a researcher in protein secretion and the relationship between translation and the emerging nascent chain. With Hitoshi Nakatogawa, he showed that the ribosomal exit tunnel can participate in recognizing the sequence of a growing protein, rather than simply providing a passive passage out of the ribosome.^[ref]

Their SecM study connected two kinds of evidence. An arrest-causing sequence in the nascent chain produced ribosome stalling, while suppressor mutations in 23S ribosomal RNA or ribosomal protein L22 allowed elongation to continue. The altered residues faced the tunnel constriction. This localization supported an interaction between the tunnel and the emerging chain.^[ref]

A simplified experiment illustrates why suppressing a phenotype is informative but does not, by itself, prove a direct physical contact. Compare four combinations: ordinary versus altered SecM, each translated by ordinary versus altered ribosomes. If an altered ribosome restores elongation specifically for the arresting sequence, the result links the two components functionally. A general reduction in translation could instead change the apparent abundance of every product; comparing only one final band would miss that alternative. Spatial information about the changed ribosomal RNA and protein residues adds another constraint. Even then, a suppressor mutation might act by changing a nearby conformation rather than removing a direct contact. The experiment is powerful because genetic and structural evidence constrain one another, while leaving room to test the detailed physical mechanism.